image
Technology - Software - Infrastructure - NASDAQ - IL
$ 17.94
1.3 %
$ 4.3 B
Market Cap
-13.29
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one CLBT stock under the worst case scenario is HIDDEN Compared to the current market price of 17.9 USD, Cellebrite DI Ltd. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one CLBT stock under the base case scenario is HIDDEN Compared to the current market price of 17.9 USD, Cellebrite DI Ltd. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one CLBT stock under the best case scenario is HIDDEN Compared to the current market price of 17.9 USD, Cellebrite DI Ltd. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CLBT

image
$26.0$26.0$25.0$25.0$24.0$24.0$23.0$23.0$22.0$22.0$21.0$21.0$20.0$20.0$19.0$19.0$18.0$18.0$17.0$17.0$16.0$16.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
401 M REVENUE
23.41%
56.9 M OPERATING INCOME
71.21%
-283 M NET INCOME
-248.96%
127 M OPERATING CASH FLOW
24.28%
-149 M INVESTING CASH FLOW
-563.15%
26 M FINANCING CASH FLOW
19.39%
109 M REVENUE
2.05%
15.7 M OPERATING INCOME
-19.12%
19.3 M NET INCOME
109.30%
60.6 M OPERATING CASH FLOW
45.58%
-15.9 M INVESTING CASH FLOW
14.55%
12.1 M FINANCING CASH FLOW
118.25%
Balance Sheet Cellebrite DI Ltd.
image
Current Assets 568 M
Cash & Short-Term Investments 447 M
Receivables 82.4 M
Other Current Assets 38 M
Non-Current Assets 123 M
Long-Term Investments 36.6 M
PP&E 27.6 M
Other Non-Current Assets 58.8 M
64.76 %11.93 %5.50 %5.30 %4.00 %8.51 %Total Assets$690.6m
Current Liabilities 296 M
Accounts Payable 11.1 M
Short-Term Debt 0
Other Current Liabilities 284 M
Non-Current Liabilities 59 M
Long-Term Debt 6.84 M
Other Non-Current Liabilities 52.2 M
3.12 %80.22 %14.72 %Total Liabilities$354.5m
EFFICIENCY
Earnings Waterfall Cellebrite DI Ltd.
image
Revenue 401 M
Cost Of Revenue 62.6 M
Gross Profit 339 M
Operating Expenses 282 M
Operating Income 56.9 M
Other Expenses 340 M
Net Income -283 M
500m500m400m400m300m300m200m200m100m100m00(100m)(100m)(200m)(200m)(300m)(300m)401m(63m)339m(282m)57m(340m)(283m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
84.40% GROSS MARGIN
84.40%
14.18% OPERATING MARGIN
14.18%
-70.54% NET MARGIN
-70.54%
-84.22% ROE
-84.22%
-40.98% ROA
-40.98%
14.77% ROIC
14.77%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Cellebrite DI Ltd.
image
120m120m100m100m80m80m60m60m40m40m20m20m00202020202021202120222022202320232024202420252025
Net Income -283 M
Depreciation & Amortization 10.6 M
Capital Expenditures -8.57 M
Stock-Based Compensation 0
Change in Working Capital 36.7 M
Others 388 M
Free Cash Flow 118 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Cellebrite DI Ltd.
image
Wall Street analysts predict an average 1-year price target for CLBT of $19.2 , with forecasts ranging from a low of $17 to a high of $23 .
CLBT Lowest Price Target Wall Street Target
17 USD -5.24%
CLBT Average Price Target Wall Street Target
19.2 USD 7.30%
CLBT Highest Price Target Wall Street Target
23 USD 28.21%
Price
Max Price Target
Min Price Target
Average Price Target
262624242222202018181616141412121010May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 5
6. Ownership
Insider Ownership Cellebrite DI Ltd.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
10 Winners Awarded “Justies” at Cellebrite's First-Ever Digital Justice Awards The premier evening celebrated the best and brightest in digital investigations, kicking off the Company's inaugural sold out Case-to-Closure User Summit for 700+ attendees The premier evening celebrated the best and brightest in digital investigations, kicking off the Company's inaugural sold out Case-to-Closure User Summit for 700+ attendees globenewswire.com - 2 weeks ago
Cellebrite Files its 2024 Annual Report on Form 20-F TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Cellebrite (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced that the Company has filed its Annual Report on Form 20-F for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission (the “SEC”). globenewswire.com - 1 month ago
SMGZY or CLBT: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Technology Services sector might want to consider either Smiths Group PLC (SMGZY) or Cellebrite DI Ltd. (CLBT). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 1 month ago
After Plunging -17.61% in 4 Weeks, Here's Why the Trend Might Reverse for Cellebrite DI Ltd. (CLBT) Cellebrite DI Ltd. (CLBT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. zacks.com - 1 month ago
Is This Stock a Next-Gen Digital Forensics Leader? In this video, Anand Chokkavelu, Travis Hoium, and Lou Whiteman discuss Cellebrite (CLBT -5.53%), a key player in digital forensics for law enforcement. They provide ratings and insights on its growth potential, management, and financials, helping you decide if this stock is a worthy investment. fool.com - 2 months ago
Cellebrite DI Ltd. (CLBT) Q4 2024 Earnings Call Transcript Cellebrite DI Ltd. (NASDAQ:CLBT ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Andrew Kramer - IR Tom Hogan - Interim CEO Dana Gerner - CFO Marcus Jewell - CRO Ronnen Armon - Chief Products and Technology Officer Conference Call Participants Shaul Eyal - TD Cowen Bhavin Shah - Deutsche Bank Eric Martinuzzi - Lake Street Charlotte Bedick - JPMorgan Jeff Rhee - Craig-Hallum Mike Cikos - Needham Tomer Zilberman - Bank of America Louie DiPalma - William Blair Operator Welcome to the Cellebrite Fourth Quarter and Full Year 2024 Financial Results Conference Call. seekingalpha.com - 2 months ago
Cellebrite DI Ltd. (CLBT) Q4 Earnings Meet Estimates Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, in line with the Zacks Consensus Estimate. zacks.com - 2 months ago
Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results Company delivers “Rule of 50” Performance in 2024 with 25% ARR growth and 25% adjusted EBITDA margin Fourth-quarter 2024 revenue of $109.0 million grew 17% primarily due to 21% growth in subscription revenue ARR grew 25% to $395.9 million Fourth-quarter 2024 adjusted EBITDA of $28.8 million, 26.4% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2024. globenewswire.com - 2 months ago
Cellebrite Government Cloud Platform Achieves FedRAMP High Ready Status Cellebrite's SaaS solution accelerates, expands and simplifies access to secure data collection and analysis Cellebrite's SaaS solution accelerates, expands and simplifies access to secure data collection and analysis globenewswire.com - 2 months ago
Cellebrite to Report Q4 Earnings: Here's What You Should Know The surge in subscription filters is likely to have benefited CLBT's top line in the fourth quarter of 2024. zacks.com - 2 months ago
Value of AI, Cloud Solutions Reign in Cellebrite's 2025 Annual Industry Trends Survey TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the release of its sixth annual 2025 Industry Trends Survey. globenewswire.com - 2 months ago
Cellebrite's Generative AI Innovations Deliver a Powerful Assistant to Expedite Investigations TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the general availability of Generative Artificial Intelligence (GenAI) capabilities within Guardian, the Company's SaaS-based evidence management solution. globenewswire.com - 2 months ago
8. Profile Summary

Cellebrite DI Ltd. CLBT

image
COUNTRY IL
INDUSTRY Software - Infrastructure
MARKET CAP $ 4.3 B
Dividend Yield 0.00%
Description Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.
Contact 94 Shlomo Shmelzer Road, Petah Tikva, 4970602 https://www.cellebrite.com
IPO Date Nov. 6, 2020
Employees 1167
Officers Ms. Ayala Berler Shapira General Counsel & Chief Compliance Officer Mr. Marcus Jewell Global Chief Revenue Officer Ms. Dana Gerner Chief Financial Officer Ms. Sigalit Shavit Chief Information Officer Andrew Kramer Vice President of Investor Relations Mr. David Nicholas Gee Chief Marketing Officer Ms. Zohar Tadmor-Eilat Chief People Officer Mr. Ronnen Armon Chief Products & Technologies Officer Mr. Thomas E. Hogan Chief Executive Officer & Director Mr. Yossi Carmil Founder